Geron reported $259.53M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Amgen USD 7.43B 1.22B Jun/2025
Bio Techne USD 1.92B 99.22M Jun/2025
Cassava Sciences USD 87.97M 57.73M Jun/2025
Cytokinetics USD -737440000 471.03M Jun/2025
Exelixis USD 2.03B 97.49M Jul/2025
Genmab DKK 5.3B 6M Jun/2025
Geron USD 259.53M 8.71M Jun/2025
Gilead Sciences USD 19.67B 596M Jun/2025
Incyte USD 4.17B 503.34M Jun/2025
MacroGenics USD 46.62M 69.44M Jun/2025
Novartis USD 42.05B 3.6B Jun/2025